Table 6.
DMPK (MLM)a |
DMPK (MLM)a |
||||||
---|---|---|---|---|---|---|---|
ID | T1/2 (min) | CLint (mL/min/mg) | ID | T1/2 (min) | CLint (mL/min/mg) | ||
Class I | 27b | 41.77 | 1.66 | 35b | 45.00 | 1.5 | |
27c | 39.94 | 1.735 | 35c | 23.66 | 2.93 | ||
31h | 7.70 | 8.90 | Class III | 35d | 49.46 | 1.4 | |
31i | 23.44 | 2.96 | 35g | 22.60 | 3.1 | ||
31j | 14.60 | 4.70 | 35h | 105.00 | 0.66 | ||
31l | 55.00 | 1.30 | 35i | 120.60 | 0.60 | ||
Class II | 31o | 50.15 | 1.40 | ||||
31q | 12.63 | 5.5 | |||||
32a | 13.29 | 5.2 | 8 22 | Antagonist | 12.35 | 5.614 | |
32c | 53.71 | 1.29 | 1 | Antagonist | 10.04b | 86.316 | |
32d | 35.46 | 1.96 | 6 | Agonist | 360.00 | 1.416 |
Compounds were incubated with MLM and cofactors for phases I and II, as described in the Experimental Section.